Retinal Nerve Fiber Layer Thickness in Prediabetic Patients

CAPOGLU, Ilyas; BİLEN, Arzu; ates, orhan; bilen, habib; ONDAŞ, Osman

doi:10.5152/eurasianjmed.2022.20420

Retinal Nerve Fiber Layer Thickness in Prediabetic Patients

Arzu BİLEN, (Atatürk Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Erzurum, Türkiye)

Orhan ATEŞ, (Atatürk Üniversitesi, Tıp Fakültesi, Oftalmoloji Anabilim Dalı, Erzurum, Türkiye)

Osman ONDAŞ, (Atatürk Üniversitesi, Tıp Fakültesi, Oftalmoloji Anabilim Dalı, Erzurum, Türkiye)

Habib BİLEN, (Atatürk Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Erzurum, Türkiye)

İlyas CAPOĞLU (Atatürk Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Erzurum, Türkiye)

Eurasian Journal of Medicine

1 0

Yıl: 2022 Cilt: 54 Sayı: 1 Sayfa Aralığı: 8 - 11 Metin Dili: İngilizce DOI: 10.5152/eurasianjmed.2022.20420 İndeks Tarihi: 24-06-2022

Retinal Nerve Fiber Layer Thickness in Prediabetic Patients

Öz:

Objective: Diabetic retinopathy is a leading cause of blindness. Diabetic retinopathy is not only seen in diabetic patients with the clinical diagnosis but also in prediabetic patients. The aim of this study is to evaluate the RNFL thickness in prediabetic patients. Materials and Methods: In this study, 50 prediabetic patients and 50 healthy individuals were included. RNFL measurements were performed with SD-OCT in patients with prediabetes and healthy controls. Results: The mean RNFL thickness for the prediabetic group was 94.7 ± 6.3 μm, inferior quadrant (120 ± 11.6), superior quadrant (112.3 ± 14.13), nasal quadrant (71 ± 12.9), and temporal quadrant (65.3 ± 9.2 μm). The mean RNFL thickness for the control group was 98.9 ± 7.5 μm, inferior quadrant (128 ± 14.7), superior quadrant (116.3 ± 15.12), nasal quadrant (77 ± 15.8), and temporal quadrant (71.2 ± 10.3 μm). Variance analysis demonstrated that the RNFL thickness difference between the groups was significant in all quadrants (P < .001). Conclusion: RNLF thinning can be seen in prediabetic patients before obvious vascular damage has occurred, and it may present in prediabetic patients not only in the temporal quadrant but also in all quadrants. The early retinal neural changes shown in this study in prediabetic patients may help to better understand the process leading to diabetic overt retinopathy.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Beulens J, Rutters F, Rydén L, et al. Risk and management of pre-diabetes. Eur J Prev Cardiol. 2019;26(2_suppl):47-54. [CrossRef]
2. Hainsworth DP, Bebu I, Aiello LP, et al. Risk factors for retinopathy in Type 1 diabetes: the DCCT/EDIC study. Diabetes Care. 2019;42(5):875-882. [CrossRef]
3. Gungor A, Ates O, Bilen H, Kocer I. Retinal nerve fiber layer thickness in early-stage diabetic retinopathy with vitamin D deficiency. Invest Ophthalmol Vis Sci. 2015;56(11):6433-6437. [CrossRef]
4. Nowacka B, Lubiński W, Honczarenko K, Potemkowski A, Safranow K. Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson's disease (PD). Doc Ophthalmol. 2015;131(2):95-104. [CrossRef]
5. van Dijk HW, Verbraak FD, Kok PH, et al. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci. 2010;51(7):3660-3665. [CrossRef]
6. American Diabetes Association. Classification and diagnosis of diabetes: <em>Standards of Medical Care in Diabetes—2018</em>. Diabetes Care. 2018;41(Suppl 1):S13-S27. [CrossRef]
7. Lamparter J, Raum P, Pfeiffer N, et al. Prevalence and associations of diabetic retinopathy in a large cohort of prediabetic subjects: the Gutenberg Health Study. J Diabetes Complications. 2014;28(4):482-487. [CrossRef]
8. Alasil T, Wang K, Keane PA, et al. Analysis of normal retinal nerve fiber layer thickness by age, sex, and race using spectral domain optical coherence tomography. J Glaucoma. 2013;22(7):532-541. [CrossRef]
9. Demir M, Oba E, Sensoz H, Ozdal E. Retinal nerve fiber layer and ganglion cell complex thickness in patients with type 2 diabetes mellitus. Indian J Ophthalmol. 2014;62(6):719-720. [CrossRef]
10. Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-281.
11. Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care. 2010;33(11):2355-2359. [CrossRef]
12. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279-2290. [CrossRef]
13. Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med. 2007;24(2):137-144. [CrossRef]
14. Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3(11):866- 875. [CrossRef]
15. Chen X, Zhao Y, Zhou Z, et al. Prevalence and risk factors of diabetic retinopathy in Chongqing pre-diabetes patients. Eye (Lond). 2012;26(6):816- 820. [CrossRef]
16. De Clerck EEB, Schouten JSAG, Berendschot TTJM, et al. Loss of temporal peripapillary retinal nerve fibers in prediabetes or Type 2 diabetes Without diabetic retinopathy: the Maastricht study. Invest Ophthalmol Vis Sci. 2017;58(2):1017-1027. [CrossRef]
17. Frydkjaer-Olsen U, Hansen RS, Peto T, Grauslund J. Structural neurodegeneration correlates with early diabetic retinopathy. Int Ophthalmol. 2018;38(4):1621-1626. [CrossRef]
18. Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2011;52(2):1156-1163. [CrossRef]
19. Alves MRP, Boia R, Campos EJ, et al. Subtle thinning of retinal layers without overt vascular and inflammatory alterations in a rat model of prediabetes. Mol Vis. 2018;24:353-366.
20. Jonsson KB, Frydkjaer-Olsen U, Grauslund J. Vascular changes and neurodegeneration in the early stages of diabetic retinopathy: which comes first? Ophthal Res. 2016;56(1):1-9. [CrossRef]
21. Phillips KC, Clarke-Farr PC, Matsha TE, Meyer D. Biomarkers as a predictor for diabetic retinopathy risk and management: a review. African Vision and Eye Health. 2018;77(1):1. [CrossRef]
22. Şahin M, Şahin A, Kılınç F, et al. Early detection of macular and peripapillary changes with spectralis optical coherence tomography in patients with prediabetes. Arch Physiol Biochem. 2018;124(1):75-79. [CrossRef]

APA	BİLEN A, ates o, ONDAŞ O, bilen h, CAPOGLU I (2022). Retinal Nerve Fiber Layer Thickness in Prediabetic Patients. , 8 - 11. 10.5152/eurasianjmed.2022.20420
Chicago	BİLEN Arzu,ates orhan,ONDAŞ Osman,bilen habib,CAPOGLU Ilyas Retinal Nerve Fiber Layer Thickness in Prediabetic Patients. (2022): 8 - 11. 10.5152/eurasianjmed.2022.20420
MLA	BİLEN Arzu,ates orhan,ONDAŞ Osman,bilen habib,CAPOGLU Ilyas Retinal Nerve Fiber Layer Thickness in Prediabetic Patients. , 2022, ss.8 - 11. 10.5152/eurasianjmed.2022.20420
AMA	BİLEN A,ates o,ONDAŞ O,bilen h,CAPOGLU I Retinal Nerve Fiber Layer Thickness in Prediabetic Patients. . 2022; 8 - 11. 10.5152/eurasianjmed.2022.20420
Vancouver	BİLEN A,ates o,ONDAŞ O,bilen h,CAPOGLU I Retinal Nerve Fiber Layer Thickness in Prediabetic Patients. . 2022; 8 - 11. 10.5152/eurasianjmed.2022.20420
IEEE	BİLEN A,ates o,ONDAŞ O,bilen h,CAPOGLU I "Retinal Nerve Fiber Layer Thickness in Prediabetic Patients." , ss.8 - 11, 2022. 10.5152/eurasianjmed.2022.20420
ISNAD	BİLEN, Arzu vd. "Retinal Nerve Fiber Layer Thickness in Prediabetic Patients". (2022), 8-11. https://doi.org/10.5152/eurasianjmed.2022.20420

APA	BİLEN A, ates o, ONDAŞ O, bilen h, CAPOGLU I (2022). Retinal Nerve Fiber Layer Thickness in Prediabetic Patients. Eurasian Journal of Medicine, 54(1), 8 - 11. 10.5152/eurasianjmed.2022.20420
Chicago	BİLEN Arzu,ates orhan,ONDAŞ Osman,bilen habib,CAPOGLU Ilyas Retinal Nerve Fiber Layer Thickness in Prediabetic Patients. Eurasian Journal of Medicine 54, no.1 (2022): 8 - 11. 10.5152/eurasianjmed.2022.20420
MLA	BİLEN Arzu,ates orhan,ONDAŞ Osman,bilen habib,CAPOGLU Ilyas Retinal Nerve Fiber Layer Thickness in Prediabetic Patients. Eurasian Journal of Medicine, vol.54, no.1, 2022, ss.8 - 11. 10.5152/eurasianjmed.2022.20420
AMA	BİLEN A,ates o,ONDAŞ O,bilen h,CAPOGLU I Retinal Nerve Fiber Layer Thickness in Prediabetic Patients. Eurasian Journal of Medicine. 2022; 54(1): 8 - 11. 10.5152/eurasianjmed.2022.20420
Vancouver	BİLEN A,ates o,ONDAŞ O,bilen h,CAPOGLU I Retinal Nerve Fiber Layer Thickness in Prediabetic Patients. Eurasian Journal of Medicine. 2022; 54(1): 8 - 11. 10.5152/eurasianjmed.2022.20420
IEEE	BİLEN A,ates o,ONDAŞ O,bilen h,CAPOGLU I "Retinal Nerve Fiber Layer Thickness in Prediabetic Patients." Eurasian Journal of Medicine, 54, ss.8 - 11, 2022. 10.5152/eurasianjmed.2022.20420
ISNAD	BİLEN, Arzu vd. "Retinal Nerve Fiber Layer Thickness in Prediabetic Patients". Eurasian Journal of Medicine 54/1 (2022), 8-11. https://doi.org/10.5152/eurasianjmed.2022.20420